Peraso Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
PRSO$0.35-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(In thousands)
| Series A Special Voting · Additional · Accumulated Other · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Common Stock · Exchangeable Shares · Paid-In · Comprehensive · Accumulated · Stockholders’ | ||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Loss | Deficit | Equity | |
| Balance as of December 31, 2021 | — | $— | 307 | $— | 233 | $— | $159,268 | $— | $(117,199) | $42,069 |
| Exchange of exchangeable shares | — | — | 5 | — | (5) | — | — | — | — | — |
| Issuance of common stock under stock plans, net of taxes paid related to net share settlements of restricted stock units | — | — | 12 | — | — | — | (119) | — | — | (119) |
| Sale of common stock and warrants | — | — | 33 | — | — | — | 2,099 | — | — | 2,099 |
| Initial recognition of fair value of warrant liability | — | — | — | — | — | — | (2,099) | — | — | (2,099) |
| Unrealized loss on available-for-sale securities | — | — | — | — | — | — | — | (25) | — | (25) |
| Stock-based compensation | — | — | — | — | — | — | 5,730 | — | — | 5,730 |
| Net loss | — | — | — | — | — | — | — | — | (32,398) | (32,398) |
| Balance as of December 31, 2022 | — | — | 357 | — | 228 | — | 164,879 | (25) | (149,597) | 15,257 |
| Exchange of exchangeable shares | — | — | 133 | 1 | (133) | — | (1) | — | — | — |
| Issuance of common stock under stock plans, net of taxes paid related to net share settlements of restricted stock units | — | — | 12 | — | — | — | (49) | — | — | (49) |
| Sale of common stock and warrants | — | — | 56 | — | — | — | 3,548 | — | — | 3,548 |
| Issuance of common stock upon exercise of warrants | — | — | 115 | — | — | — | 46 | — | — | 46 |
| Initial recognition of fair value of warrant liability | — | — | — | — | — | — | (3,162) | — | — | (3,162) |
| Unrealized gain on available-for-sale securities | — | — | — | — | — | — | — | 25 | — | 25 |
| Stock-based compensation | — | — | — | — | — | — | 5,213 | — | — | 5,213 |
| Net loss | — | — | — | — | — | — | — | — | (16,795) | (16,795) |
| Balance as of December 31, 2023 | — | $— | 673 | $1 | 95 | $— | $170,474 | $— | $(166,392) | $4,083 |
Note: Share amounts for the year ended December 31, 2023 and 2022 have been adjusted to reflect the impact of a 1-for-40 reverse stock split of the Company’s common stock and exchangeable shares effected in January 2024, as discussed in Note 1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.